World Health Organization |

Scientists Converge in Record Numbers as 2025 CPHIA Opens in Durban

October 23, 2025October 23, 2025 Michael Gwarisa

By Michael Gwarisa in Durban, South Africa Registration data show that approximately 800 scientists and researchers from various scientific disciplines had registered for participation by the opening day of the 2025 Conference for Public Health in Africa (CPHIA) in Durban, South Africa. The conference runs from October 22 to 25, 2025 under the theme “Moving Towards Self-Reliance to Achieve Universal Health Coverage and Health Security in Africa.” It is aimed at deliberating on numerous issues affecting healthcare. Officiating at the opening ceremony of the 4th CPHIA, South Africa’s Deputy Minister…

SC Johnson Wins WHO Backing for New Tool to Prevent Malaria and Other Insect-Borne Diseases

August 15, 2025 Michael Gwarisa

By Staff Reporter NAIROBI, KENYA, August 15, 2025 – Today, the World Health Organization (WHO) announced a policy recommendation for spatial repellents to be used as an innovative tool to help fight insect-borne diseases like malaria. SC Johnson, maker of household brands such as OFF!®, Baygon® and Raid® and leaders in insect science, has been working towards this achievement for more than a decade and has already been distributing millions of its own company-developed and manufactured spatial repellents – SC Johnson Guardian™ and SC Johnson Mosquito Shield™ – to communities…

Ebola Breaks Out in Uganda as US Halts Foreign Aid

February 5, 2025February 5, 2025 Healthtimes

By Nakisanze Segawa, GPJ Uganda KAMPALA, UGANDA — One nurse died from the Sudan Ebola virus in Uganda on Jan. 29. Two more cases were confirmed days later — and hundreds of people were direct contacts. The virus spreads fast, and it’s deadly: The Sudan strain’s fatality rate ranged from 40% to 100% in past outbreaks, and there are no approved vaccines. Now, the United States Agency for International Development, a key partner in treating Ebola and slowing its spread, has stopped all funding for global health and all of…

They Earn More Money, But Some Migrant Health Workers Say It’s Not Worth It

January 23, 2025 Healthtimes

By Gamuchirai Masiyiwa, GPJ Zimbabwe HARARE, ZIMBABWE — When Tanya moved to Ireland for care work in 2022, she was certain of three things: Her family would join her soon. Her husband would find work. And her children would attend a good school. Initially, her move was smooth. Visas and permits were no problem. But once in Ireland, reality proved harsh for Tanya, a Zimbabwean who asked Global Press Journal to use her middle name for fear of jeopardizing her visa status. The country’s visa restrictions for the general employment…

Health Resilience Fund Support Enhances Uptake Of Long-Term Family Planning Methods In Matabeleland South

June 16, 2024June 16, 2024 Michael Gwarisa

By Michael Gwarisa in Gwanda The risk of unplanned pregnancies is very high in the absence of Long-Acting Reversible Contraceptives (LARCs) Family planning methods. Women in low-resource settings experience interruptions that may increase the risk of unintended and unplanned pregnancies. In most cases, the poorest couples have the highest fertility, the lowest contraceptive use and the highest unmet need for contraception. In Gwanda, Matabeleland South, women such Florence Kungai (31), from Gwanda who in the past experienced two separate occasions of contraceptive failure due to interruptions in her schedule, now…

Zim targets 4.2 million children in emergency polio vaccination

February 16, 2024February 16, 2024 Kuda Pembere

By Kudakwashe Pembere Having detected some cases of vaccine-derived poliovirus type 2 (cVDPV) in Harare, another has been identified in Sanyati, a district in Mashonaland West prompting Zimbabwe’s health authorities to activate an emergency vaccination campaign for children below 10 years of age this month. The vaccination blitz intends to vaccinate 4.2 million children across the country. Addressing journalists on Friday,Deputy Health and Child Care Minister Honorable Sleiman Timios Kwidini said through their surveillance mechanisms they identified a case which was confirmed via laboratory tests. “The Ministry of Health and…

Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial

January 30, 2021 Healthtimes

Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key secondary endpoints. The topline safety and efficacy data are based on 43,783 participants accruing 468 symptomatic cases of COVID-19. The Phase 3 ENSEMBLE study is designed to evaluate the efficacy and safety of the Janssen COVID-19 vaccine candidate in protecting moderate to severe COVID-19, with co-primary endpoints of 14 days…